Skip to main content

Table 1 Socio-demographic and baseline characteristics according to stroke mechanism in French Guiana. India study-French Guiana

From: The epidemiology and management of stroke in French Guiana

CharacteristicsAll patients
N = 298
Ischemic stroke
N = 234 [78.5%]
Intracerebral hemorrhage
N = 64 [21.4%]
Demographic characteristics
 Age
  < 5060 (20.1)43 (18.3)17 (26.5)
  50–65106 (35.5)86 (36.7)20 (31.2)
  65–8096 (32.2)77 (32.9)19 (29.6)
  ≥8036 (12)28 (11.9)8 (12.5)
 Male gender190 (63.7)146 (62.3)44 (68.7)
Preexisting conditions
 BMI±
  <  2016 (5.3)11 (4.7)5 (7.8)
  20–2582 (27.5)60 (25.6)22 (34.3)
  25–3082 (27.5)68 (29)14 (21.8)
  > = 3052 (17.4)41 (17.5)11 (17.1)
  Unknown66 (22.1)54 (23)12 (18.7)
 Hypertension±208 (70.2)164 (70.3)44 (69.8)
 Diabetes±74 (24.9)67 (28.7)7 (10.9)
 Hypercholesterolemia±50 (17)42 (18.1)8 (12.7)
 Chronic heart failure±16 (5.4)12 (5.1)4 (6.2)
 Alcohol ≥ 2 drinks/day±52 (17.9)35 (15.2)17 (27.8)
 Tobacco status±
  Current smoker64 (21.6)53 (22.7)11 (17.7)
  Previous smoker48 (16.2)37 (15.8)11 (17.7)
  Non smoker183 (62)143 (61.3)40 (64.5)
 Atrial fibrillation±19 (6.5)17 (7.4)2 (3.1)
 Prior medical history
  Prior transient ischemic attack33 (11)33 (14.1)0
  Prior myocardial infarction8 (2.6)5 (2.1)3 (4.6)
  Prior angina pectoris9 (3)6 (2.5)3 (4.6)
  Prior history of lower limb arteriopathy13 (4.3)13 (5.5)0
  Prior history of vascular surgery7 (2.3)7 (2.9)0
  Prior history of angioplasty7 (2.3)6 (2.5)1 (1.5)
 Pre-morbid treatment
  Antiplatelet therapy41 (13.7)34 (14.5)7 (10.9)
  Anticoagulant therapy±19 (6.4)10 (4.3)9 (14)
  Antihypertensive drug±153 (51.6)120 (51.7)33 (51.5)
  Statin±38 (12.7)31 (13.3)7 (10.9)
  Oral antidiabetic drug±48 (16.2)44 (18.9)4 (6.2)
  Psychotropic drug±15 (5)9 (3.8)6 (9.3)
  Insulin±24 (8)21 (9)3 (4.6)
  Oral contraception ±(woman only)7 (6.4)7 (7.9)0
  Substitution hormonotherapy ±(woman only)2 (1.9)02 (1.9)
 Ischaemic stroke classification (n = 234)
  Lacunar 57 (24.3) 
  Large-artery 38 (16.2) 
  Cardioembolism 28 (11.9) 
  Other 111 (47.4) 
 Admission NIHSS score±
  0–389 (31.4)75 (33.7)14 (22.9)
  4–997 (34.2)84 (37.8)13 (21.3)
  ≥1097 (34.2)63 (28.3)34 (55.7)
 mRS at discharge±
  040 (14.3)37 (17.1)3 (4.8)
  1–2102 (36.6)88 (40.7)14 (22.5)
  3–496 (34.5)67 (31)29 (46.7)
  1. ± missing values: BMI = 66; HTA = 2; Diabetes = 1; Hypercholesterolemia = 4; Chronic heart failure = 3; Alcohol = 8;Tobbaco = 3; AF = 6; anticoagulant = 2; antihypertensive = 2; statin = 1; oral antidiabetic = 2; psychotropic = 1; insulin = 1; oral contraception = 2; Sub hormonotherapy = 4; pre stroke mRS = 1; NIHSS at admission = 15; Barthel score = 2